Your browser doesn't support javascript.
loading
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model.
Bilal, Hajira; Bergen, Phillip J; Kim, Tae Hwan; Chung, Seung Eun; Peleg, Anton Y; Oliver, Antonio; Nation, Roger L; Landersdorfer, Cornelia B.
Afiliação
  • Bilal H; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Bergen PJ; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Kim TH; College of Pharmacy, Daegu Catholic University, Gyeongbuk, Republic of Korea.
  • Chung SE; School of Pharmacy, Sungkyunkwan University, Seoul, Republic of Korea.
  • Peleg AY; Department of Infectious Diseases, The Alfred Hospital and Central Clinical School, Monash University, Melbourne, Australia.
  • Oliver A; Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Nation RL; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
  • Landersdorfer CB; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia cornelia.landersdorfer@monash.edu.
Article em En | MEDLINE | ID: mdl-31427301

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Tobramicina / Biofilmes / Meropeném Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pseudomonas aeruginosa / Infecções por Pseudomonas / Tobramicina / Biofilmes / Meropeném Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article